概要
TwoStep Therapeutics, a Stanford spinout, develops multi-specific targeted therapies for solid tumors using a proprietary polyspecific integrin-binding peptide platform. The platform is a small synthetic peptide scaffold engaging five tumor-associated integrins, designed as a modular targeting core for peptide-drug conjugates and radioligand therapies.
資金調達
| ラウンド |
金額 |
発表日 |
投資家 |
|
Series A
|
会員限定 |
会員限定 |
投資家 7社 |